Ona Therapeutics
First-in-class ADCs tailored to attack advanced cancer.
Barcelona, United States · Founded 2019 · $152.1M raised
- Headquarters
- Barcelona
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- ona-therapeutics.com
- Total Funding
- $152.1M
- Last Round
- $86.6M Venture RoundJun 2026
- Rounds
- 4
About
Ona Therapeutics is a Barcelona-based biotech spun out of ICREA and IRB Barcelona, pioneering first-in-class antibody drug conjugates (ADCs) for advanced, treatment-refractory cancers. The company identifies novel therapeutic targets from real-world refractory patient samples.
Summary
Ona Therapeutics is a Biotech company based in Barcelona, United States, founded in 2019. It has raised $152.1M in total across 4 rounds, most recently a $86.6M Venture Round round in Jun 2026. Investors include Asabys Partners, Ysios Capital and Alta Life Sciences.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...